A GLP-1 plan refers to a structured treatment programme involving glucagon-like peptide-1 (GLP-1) receptor agonist medications, primarily used for managing type 2 diabetes and, more recently, obesity
Clinical efficacy : Large randomised controlled trials demonstrate that GLP-1 receptor agonists can reduce HbA1c by approximately 1.01.5% and produce weight loss of 515% of body weight, with the higher end of weight loss typically seen with higher-dose semaglutide (2.4mg/Wegovy) specifically for obesity treatment
Procurement and PI sign-offs can pull historical lot data directly from the page, which makes audit trails easier to build before a purchase order goes out
Compounded semaglutide is often used as a weight loss medication
Critically, you don't actually need to have eaten or be full for semaglutide to work
Additionally, inadequate protein intake can lead to muscle loss and weakness, while insufficient iron, vitamin B12, or vitamin D can cause fatigue